Adults 8 to 17, any sex, with Hearing Loss. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Speech Reception ThresholdPrimary· Initial appointment (day 1 of study) and 2nd appointment (Day 14 of study)
A familiar spondee word list is presented at varying dB (decibel) levels. Threshold is defined as the lowest dB level at which a correct response occurs for two out of three ascending trials. Testing was completed in two, two-hour test sessions occurring two weeks apart. A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session, and counterbalanced across participants. Each session consisted of testing with the ASG (Adaptive Situational Gain) feature on and off. The lower the number (dB level), the softer the partic
NAL Fitting with ASG Off
Group
Value
95% CI
Experimental
27
± 8
NAL Fitting with ASG ON
Group
Value
95% CI
Experimental
27
± 7
DSL Fitting with ASG Off
Group
Value
95% CI
Experimental
24
± 8
DSL Fitting with ASG On
Group
Value
95% CI
Experimental
24
± 6
Word Recognition Score With Words Presented at 40 dB SPL (Decibel Sound Pressure Level) and 70 dB SPL.Primary· Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
Familiar monosyllabic word list presented at 40 dB and 70 dB. Percentage of words correctly repeated is calculated. Testing was completed in two, two-hour test sessions occurring two weeks apart. A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off. The higher the score, the better
% correct at 40 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
52
± 24
% correct at 40 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
63
± 26
% correct at 40 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
69
± 21
% correct at 40 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
75
± 22
% correct at 70 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
92
± 10
% correct at 70 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
95
± 5
% correct at 70 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
95
± 6
% correct, DSL fitting, ASG On
Group
Value
95% CI
Experimental
96
± 7
Multi-word Recognition at 40 dB SPL and 70 dB SPLPrimary· Initial appointment (Day 1 of study) and 2nd appointment (Day 14 of study)
Out of a list of seven words, the participant repeats back as many words as they can recall. Percentage of correct words repeated back is calculated. Testing was completed in two, two-hour test sessions occurring two weeks apart. One fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NAL or DSL, but with both levels (40 and 70 dB) and with both ASG (Adaptive Situational Gain) settings, on and off. A highe
% correct at 40 dB for NAL fitting, ASG Off
Group
Value
95% CI
Experimental
48
± 20
% correct at 40 dB for NAL fitting, ASG On
Group
Value
95% CI
Experimental
56
± 16
% correct at 40 dB for DSL fitting, ASG Off
Group
Value
95% CI
Experimental
51
± 16
% correct at 40 dB for DSL fitting, ASG On
Group
Value
95% CI
Experimental
54
± 16
% correct at 70 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
66
± 17
% correct at 70 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
67
± 13
% correct at 70 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
63
± 13
% correct at 70 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
67
± 13
Nonword Detection Presented at 40 dB SPL and at 70 dB SPL.Primary· Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
A list of 10 3-word phrases are presented to the participant. The participant indicates if the phrase contains a nonsense word by selecting the numbered response button (i.e. "1", "2", or "3") that corresponds to the position oof the nonsense word in the phrase. Testing was completed in two, two-hour test sessions occurring two weeks apart. A different fitting prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for each test session and counterbalanced across participants such that one test session consisted of testing with one prescription, either NA
% correct at 40 dB, NAL fitting formula, ASG Off
Group
Value
95% CI
Experimental
65
± 15
% correct at 40 dB, NAL fitting with ASG On
Group
Value
95% CI
Experimental
68
± 13
% correct at 40 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
73
± 18
% correct at 40 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
71
± 12
% correct at 70 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
89
± 7
% correct at 70 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
87
± 7
% correct at 70 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
88
± 9
% correct at 70 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
87
± 7
Rapid Word Learning With Stimuli Presented at 40 dB SPL and at 70 dB SPL.Primary· Initial appointment (Day 1 of study) and 2nd appointment (day 14 of study)
A word learning task used to determine participant's ability to associate novel/nonsense words with novel images as rapidly as possible. Five nonsense words are paired with five novel images displayed on response buttons. The words are presented randomly 10 times each. The participant selects one picture per word. Scores are presented as percent correct. A higher percentage indicates better word learning. Testing was completed in two, two-hour test sessions occurring two weeks apart. A different prescription, NAL (National Acoustic Laboratory) or DSL (Desired Sensation Level) was selected for
% correct at 40 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
68
± 23
% correct at 40 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
76
± 18
% correct at 40 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
70
± 22
% correct at 40 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
73
± 20
% correct at 70 dB, NAL fitting, ASG Off
Group
Value
95% CI
Experimental
69
± 18
% correct at 70 dB, NAL fitting, ASG On
Group
Value
95% CI
Experimental
73
± 16
% correct at 70 dB, DSL fitting, ASG Off
Group
Value
95% CI
Experimental
67
± 20
% correct at 70 dB, DSL fitting, ASG On
Group
Value
95% CI
Experimental
70
± 21
Subjective Preference for the Adaptive Situational Gain Feature With Each Fitting FormulaPrimary· 2nd appointment (day 14 of study)
Participants will rank preference for the ASG feature (either on or off) in each fitting (NAL and DSL) after listening to audio file.
Number of participants preferring ASG Off with NAL fitting
Group
Value
95% CI
Experimental
2
Number of participants preferring ASG On with NAL fitting
Group
Value
95% CI
Experimental
2
Number of participants preferring ASG Off with DSL fitting
Group
Value
95% CI
Experimental
7
Number of participants preferring ASG On with DSL fitting
Group
Value
95% CI
Experimental
3
Sponsor's own description
Comfort and clarity of speech will be measured in hearing impaired children age 8-17 using standard speech processing algorithm with a soft speech enhancer feature, referred to as the Adaptive Situational Gain (ASG) feature in study documents.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
NCT05072470 — Benefits of Assistive Listening Device for Speech Intelligibility
· NA
· completed
NCT04995666 — Hearing Aid Quality and Reliability Study
· NA
· completed
NCT04953390 — Evaluating Benefits of Hearing Aid Microphone Directionality Technologies
· NA
· completed
Other recruiting trials for Hearing Loss
Currently open trials in the same condition.
NCT07176936 — Improving Speech in Noise Using Noninvasive Stimulation
· NA
· recruiting
NCT07506408 — Randomised Study of Web-Based Auditory Training With Varying Perceptual and Cognitive Demands on Training Gains and Gene
· NA
· recruiting
NCT07218913 — Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III
· Phase 1
· recruiting
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06930560 — HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
· NA
· recruiting
Other Sonova AG trials
Trials by the same sponsor.
NCT07526428 — Investigating the DNN Noise Reduction Feature in Phonak Hearing Aids Using Ecological Momentary Assessment
· NA
· enrolling by invitation
NCT07501312 — Remote Microphone Performance Comparison in Adults With Hearing Loss
· NA
· enrolling by invitation
NCT07414329 — Efficacy and Effectiveness of an Investigational Behind-the-Ear Hearing Device Kit
· NA
· recruiting
NCT06957730 — A Comparison of Hearing Aid Noise Programs on Speech Intelligibility
· NA
· completed
NCT06746038 — Evaluation of Extended Wear Hearing Aid for Mild Hearing Loss
· NA
· not yet recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sonova AG
Last refreshed: 19 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05150964.